Clarius Group LLC’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $859K | Sell |
2,118
-676
| -24% | -$274K | 0.05% | 165 |
|
2025
Q1 | $1.39M | Sell |
2,794
-190
| -6% | -$94.5K | 0.09% | 104 |
|
2024
Q4 | $1.55M | Buy |
2,984
+176
| +6% | +$91.6K | 0.11% | 87 |
|
2024
Q3 | $1.73M | Sell |
2,808
-68
| -2% | -$41.8K | 0.12% | 81 |
|
2024
Q2 | $1.59M | Buy |
2,876
+349
| +14% | +$193K | 0.11% | 85 |
|
2024
Q1 | $1.47M | Sell |
2,527
-453
| -15% | -$263K | 0.1% | 90 |
|
2023
Q4 | $1.58M | Sell |
2,980
-759
| -20% | -$403K | 0.13% | 90 |
|
2023
Q3 | $1.89M | Sell |
3,739
-1,010
| -21% | -$511K | 0.18% | 65 |
|
2023
Q2 | $2.48M | Sell |
4,749
-141
| -3% | -$73.6K | 0.19% | 63 |
|
2023
Q1 | $2.82M | Sell |
4,890
-126
| -3% | -$72.6K | 0.24% | 52 |
|
2022
Q4 | $2.76M | Sell |
5,016
-105
| -2% | -$57.8K | 0.25% | 57 |
|
2022
Q3 | $2.6M | Buy |
5,121
+216
| +4% | +$110K | 0.26% | 52 |
|
2022
Q2 | $2.67M | Sell |
4,905
-722
| -13% | -$392K | 0.27% | 49 |
|
2022
Q1 | $3.76M | Hold |
5,627
| – | – | 0.3% | 41 |
|
2021
Q4 | $3.76M | Sell |
5,627
-388
| -6% | -$259K | 0.3% | 41 |
|
2021
Q3 | $3.44M | Buy |
6,015
+131
| +2% | +$74.8K | 0.31% | 42 |
|
2021
Q2 | $2.97M | Buy |
+5,884
| New | +$2.97M | 0.27% | 45 |
|
2021
Q1 | – | Sell |
-4,122
| Closed | -$1.92M | – | 399 |
|
2020
Q4 | $1.92M | Buy |
4,122
+511
| +14% | +$238K | 0.21% | 52 |
|
2020
Q3 | $1.59M | Sell |
3,611
-352
| -9% | -$155K | 0.2% | 56 |
|
2020
Q2 | $1.44M | Buy |
3,963
+746
| +23% | +$270K | 0.2% | 60 |
|
2020
Q1 | $912K | Buy |
3,217
+261
| +9% | +$74K | 0.17% | 71 |
|
2019
Q4 | $991K | Sell |
2,956
-6
| -0.2% | -$2.01K | 0.16% | 76 |
|
2019
Q3 | $863K | Buy |
2,962
+355
| +14% | +$103K | 0.16% | 81 |
|
2019
Q2 | $765K | Buy |
2,607
+296
| +13% | +$86.9K | 0.15% | 79 |
|
2019
Q1 | $633K | Buy |
+2,311
| New | +$633K | 0.15% | 82 |
|